TLX News: Telix Announces Cardinal Health as U.S. Commercial Distributor for Zircaix® - 18th Sep 2024, 7:00am

[annb0t]

MELBOURNE, Australia, Sept. 18, 2024 /PRNewswire/ -- Telix Pharmaceuticals Limited (ASX: TLX, Telix, the Company) today announces that it has selected Cardinal Health, Inc. (NYSE: CAH, Cardinal Health) as a commercial radiopharmaceutical distributor to supply finished unit doses of its PET[1] agent, Zircaix®[2] (TLX250-CDx) for the imaging of kidney cancer in the United States (U.S.), subject to regulatory approval. (PRNewsfoto/Telix Pharmaceuticals Limited)

In preparation for a planned comm...

>>> Read more: Telix Announces Cardinal Health as U.S. Commercial Distributor for Zircaix®